AngioDynamics, Inc. Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share
AngioDynamics, Inc. (ANGO) reported Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share of $0.00 per share for the 12-month period ending 2021-05-31, per its 10-K filed 2021-07-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare · last filed 2021-07-27
- AngioDynamics, Inc. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for the quarter ending 2020-02-29 was $0.00, a 100.00% decline year-over-year.
- AngioDynamics, Inc. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for the quarter ending 2019-11-30 was $0.00, a 100.00% decline year-over-year.
- AngioDynamics, Inc. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for the quarter ending 2019-08-31 was $0.00, a 100.00% decline year-over-year.
- AngioDynamics, Inc. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for the quarter ending 2019-05-31 was $1.49, a 520.83% increase year-over-year.
- AngioDynamics, Inc. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for fiscal 2021 was $0.00.
- AngioDynamics, Inc. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- AngioDynamics, Inc. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for fiscal 2019 was $1.93, a 216.39% increase from fiscal 2018.
- AngioDynamics, Inc. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for fiscal 2018 was $0.61, a 84.85% increase from fiscal 2017.
| Period end | Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share 3 month | Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share 6 month | Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share 9 month | Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share 12 month |
|---|---|---|---|---|
| 2021-05-31 | $0.00 10-K · filed 2021-07-27 | |||
| 2020-05-31 | $0.00 10-K · filed 2021-07-27 | |||
| 2020-02-29 | $0.00 10-Q · filed 2020-04-08 | $0.00 10-Q · filed 2020-04-08 | ||
| 2019-11-30 | $0.00 10-Q · filed 2020-01-08 | $0.00 10-Q · filed 2020-01-08 | ||
| 2019-08-31 | $0.00 10-Q · filed 2019-10-04 | |||
| 2019-05-31 | $1.49 10-K · filed 2020-08-10 | $1.93 10-K · filed 2021-07-27 | ||
| 2019-02-28 | $0.14 10-K · filed 2020-08-10 | $0.44 10-Q · filed 2020-04-08 | ||
| 2018-11-30 | $0.15 10-K · filed 2020-08-10 | $0.29 10-Q · filed 2020-01-08 | ||
| 2018-08-31 | $0.14 10-K · filed 2020-08-10 | |||
| 2018-05-31 | $0.24 10-K · filed 2019-07-25 | $0.61 10-K · filed 2020-08-10 | ||
| 2018-02-28 | $0.11 10-K · filed 2019-07-25 | |||
| 2017-11-30 | $0.13 10-K · filed 2019-07-25 | |||
| 2017-08-31 | $0.13 10-K · filed 2019-07-25 | |||
| 2017-05-31 | $0.33 10-K · filed 2019-07-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |